Sandy Spring Bank Vertex Pharmaceuticals Inc Transaction History

Sandy Spring Bank

  • $2.33 Billion
  • Q1 2025

A detailed history of Sandy Spring Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sandy Spring Bank holds 6,391 shares of VRTX stock, worth $2.94 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
6,391
Previous 4,776 33.81%
Holding current value
$2.94 Million
Previous $1.92 Million 61.1%
% of portfolio
0.13%
Previous 0.08%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$402.49 - $513.76 $650,021 - $829,722
1,615 Added 33.81%
6,391 $3.1 Million
Q4 2024

Feb 11, 2025
BUY
$396.64 - $516.74 $1.44 Million - $1.87 Million
3,621 Added 313.51%
4,776 $1.92 Million
Q3 2024

Oct 25, 2024
BUY
$460.0 - $505.78 $374,900 - $412,210
815 Added 239.71%
1,155 $537,000
Q2 2024

Aug 06, 2024
BUY
$392.81 - $485.53 $14,533 - $17,964
37 Added 12.21%
340 $159,000
Q1 2024

May 08, 2024
BUY
$407.69 - $446.08 $42,807 - $46,838
105 Added 53.03%
303 $126,000
Q4 2023

Jan 26, 2024
BUY
$343.0 - $410.68 $62,083 - $74,333
181 Added 1064.71%
198 $80,000
Q2 2023

Aug 04, 2023
SELL
$314.42 - $351.91 $19,179 - $21,466
-61 Reduced 78.21%
17 $5,000
Q1 2023

May 05, 2023
BUY
$283.23 - $323.1 $20,109 - $22,940
71 Added 1014.29%
78 $24,000
Q4 2022

Feb 10, 2023
SELL
$285.76 - $321.48 $4,572 - $5,143
-16 Reduced 69.57%
7 $2,000
Q3 2022

Nov 02, 2022
BUY
$273.83 - $305.53 $4,381 - $4,888
16 Added 228.57%
23 $7,000
Q4 2021

Feb 11, 2022
SELL
$177.01 - $223.45 $17,701 - $22,345
-100 Reduced 93.46%
7 $2,000
Q2 2021

Aug 09, 2021
SELL
$187.49 - $221.1 $1,124 - $1,326
-6 Reduced 5.31%
107 $21,000
Q1 2021

May 03, 2021
BUY
$207.02 - $241.31 $1,449 - $1,689
7 Added 6.6%
113 $25,000
Q4 2020

Feb 03, 2021
SELL
$207.01 - $276.09 $40,159 - $53,561
-194 Reduced 64.67%
106 $25,000
Q3 2020

Nov 09, 2020
SELL
$255.65 - $303.1 $3,579 - $4,243
-14 Reduced 4.46%
300 $82,000
Q1 2020

May 01, 2020
BUY
$199.77 - $247.81 $2,796 - $3,469
14 Added 4.67%
314 $75,000
Q2 2019

Aug 01, 2019
SELL
$164.61 - $190.37 $4,444 - $5,139
-27 Reduced 8.26%
300 $55,000
Q1 2019

May 06, 2019
BUY
$163.73 - $194.7 $4,420 - $5,256
27 Added 9.0%
327 $60,000
Q2 2018

Aug 03, 2018
SELL
$145.72 - $169.96 $6,703 - $7,818
-46 Reduced 13.29%
300 $51,000
Q1 2018

May 04, 2018
BUY
$151.6 - $177.13 $45,480 - $53,139
300 Added 652.17%
346 $56,000
Q4 2017

Feb 02, 2018
BUY
$137.28 - $155.55 $6,314 - $7,155
46
46 $7,000

Others Institutions Holding VRTX

# of Institutions
1,834
Shares Held
233M
Call Options Held
1.38M
Put Options Held
1.08M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $118B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email